Surgical Equipment Stocks Beat Q2 Revenue Estimates by 1.6%

Earnings
โดย StockStory·US·Read original
Summary · why it matters

Surgical equipment and consumables stocks tracked by StockStory delivered a strong second quarter, with group revenues beating analysts' consensus estimates by 1.6%. STERIS reported revenues of $1.49 billion, up 7.3% year on year, in line with expectations but with the weakest performance against analyst estimates of the group. Solventum posted revenues of $2.21 billion, up 2.2% year on year, outperforming expectations by 2.5% and delivering the biggest analyst estimate beat among its peers. Zimmer Biomet reported revenues of $2.18 billion, up 4.8% year on year, exceeding expectations by 2%, while CONMED reported revenues of $343.5 million, flat year on year, beating expectations by 1.8%. BD reported revenues of $4.98 billion, up 5.4% year on year, topping expectations by 2%.

Impact on stocks 5

Health Care▲ · 2 stocks
CONMED Corporation
CNMD
▲ PositiveCapitalrelevance

CONMED reported Q2 revenues of $343.5M, flat YoY, beating expectations by 1.8%.

STERIS plc
STE
± MixedCapitalrelevance

STERIS reported Q2 revenues of $1.49B, up 7.3% YoY, in line with expectations but weakest against analyst estimates.

Biotech & Genomic Medicine▲ · 1 stocks
Aging Population▲ · 1 stocks
Solventum Corp.
SOLV
▲ PositiveCapitalrelevance

Solventum posted Q2 revenues of $2.21B, up 2.2% YoY, outperforming expectations by 2.5%.

Robotics & Physical AI▲ · 1 stocks
© 2026 MarketDXNews